Buy or sell A2 Biotherapeutics stock pre IPO via an EquityZen fund

EquityZen is a marketplace for shares of proven pre IPO tech companies

A2 Biotherapeutics Stock

A2 Biotherapeutics develops novel medicines for serious illness.

About A2 Biotherapeutics Stock

A2 Biotherapeutics is an early-stage biotechnology company located in Southern California that develops novel medicines for serious illnesses. We utilize an advanced targeting technology platform to increase the effectiveness of the body’s natural immune defenses.

Funding History

November 2019$57.0M
October 2020$71.5M

Management

Sr Director Technology

Han Xu

Independent Director

Madhavan Balachandran

Vice President, Head of Technical Operations

Michelle Kreke

Vice President Operations

David Lucas

Senior Director Drug Discovery

Agi Hamburger

President and CSO

Alexander Kamb

Join 290K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

LogoLogo